Oclacitinib is a veterinary Janus kinase (JAK) inhibitor utilized to manage atopic dermatitis and allergic itchiness in dogs by inhibiting the signaling pathways responsible for inflammation. This category… Read more
![Chemical structure of [trans-4-[(tert-Butoxycarbonyl)amino]cyclohexyl]methyl 4-methylbenzenesulfonate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F947141-76-6-trans-4-tert-Butoxycarbonylaminocyclohexylmethyl-4-methylbenzenesulfonate.png&w=3840&q=75)



![Chemical structure of rel-((1r,4r)-4-(Methyl(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methyl 4-methylbenzenesulfonate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1208319-32-7-rel-1r4r-4-Methyl7-tosyl-7H-pyrrolo23-dpyrimidin-4-ylaminocyclohexylmethyl-4-methylbenzenesulfonate.png&w=3840&q=75)

![Chemical structure of trans-4-[Methyl[7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]cyclohexanemethanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2538954-26-4-trans-4-Methyl7-4-methylphenylsulfonyl-7H-pyrrolo23-dpyrimidin-4-ylaminocyclohexanemethanol.png&w=3840&q=75)
![Chemical structure of trans-N,N-Dimethyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1312034-35-7-trans-NN-Dimethyl-4-methyl-7H-pyrrolo23-dpyrimidin-4-ylaminocyclohexanemethanesulfonamide.png&w=3840&q=75)
Oclacitinib is a veterinary Janus kinase (JAK) inhibitor utilized to manage atopic dermatitis and allergic itchiness in dogs by inhibiting the signaling pathways responsible for inflammation. This category contains a comprehensive selection of Oclacitinib reference standards, including the active pharmaceutical ingredient, related impurities, and stable isotope-labelled compounds. Pharmaceutical laboratories use these high-quality materials for impurity profiling, method validation, and routine quality control of veterinary drug formulations. By providing access to specific degradation products, synthesis intermediates, and isotope-labelled internal standards, such as Oclacitinib-13C-d3, this collection ensures that analytical scientists can accurately identify and quantify potential contaminants. These reference standards are essential for maintaining rigorous safety and efficacy standards throughout the development, manufacturing, and regulatory review of Oclacitinib-based products.